Expression of corticotropin releasing factor receptor type 1 (CRF1) in the human gastrointestinal tract and upregulation in the colonic mucosa in patients with ulcerative colitis.
about
Role of Corticotropin-releasing Factor in Gastrointestinal Permeability.CRF and urocortin peptides as modulators of energy balance and feeding behavior during stress.Multi-facets of Corticotropin-releasing Factor in Modulating Inflammation and Angiogenesis.Role of Corticotropin-releasing Factor Signaling in Stress-related Alterations of Colonic Motility and Hyperalgesia.Lesional accumulation of CD163-expressing cells in the gut of patients with inflammatory bowel disease.The joint power of sex and stress to modulate brain-gut-microbiota axis and intestinal barrier homeostasis: implications for irritable bowel syndrome.Buserelin treatment to rats causes enteric neurodegeneration with moderate effects on CRF-immunoreactive neurons and Enterobacteriaceae in colon, and in acetylcholine-mediated permeability in ileumCorticotropin-releasing factor receptor subtype 2 in human colonic mucosa: down-regulation in ulcerative colitisCorticotropin-Releasing Factor and Toll-Like Receptor Gene Expression Is Associated with Low-Grade Inflammation in Irritable Bowel Syndrome Patients with Depression.Sex hormones in the modulation of irritable bowel syndrome.Repeated otilonium bromide administration prevents neurotransmitter changes in colon of rats underwent to wrap restraint stress.Expression of corticotropin-releasing factor and urocortins in the normal and Schistosoma mansoni-infected mouse ileum.Molecular and functional diversity of GABA-A receptors in the enteric nervous system of the mouse colon.Altered brain and gut responses to corticotropin-releasing hormone (CRH) in patients with irritable bowel syndrome.Frontline Science: Corticotropin-releasing factor receptor subtype 1 is a critical modulator of mast cell degranulation and stress-induced pathophysiology.Experimental Models of Irritable Bowel Syndrome and the Role of the Enteric Neurotransmission.The Influence of Early Life Experience on Visceral Pain.Activation of corticotropin-releasing factor receptor 1 aggravates dextran sodium sulphate-induced colitis in mice by promoting M1 macrophage polarization.Involvement of Corticotropin-Releasing Factor and Receptors in Immune Cells in Irritable Bowel Syndrome.Changes of excitatory and inhibitory neurotransmitters in the colon of rats underwent to the wrap partial restraint stress.
P2860
Q30421083-FC1A86B0-EFC6-45C4-8A15-97386AF71610Q34412317-4600AEE0-9288-4D6A-8242-234061C29AE0Q34882241-3E06CA81-A1AB-427A-A2FC-C1EC962F1142Q34882307-519232B2-81F1-4889-801E-1D6BE0B4EB3FQ34904199-C4ED3D9A-9504-4C96-AE0A-6A3A60958135Q35838055-BF0E626A-6D37-4AD0-BADD-B629CC23E3D6Q35879842-CC8F357C-E184-4DF0-8F60-2FE9DE63F50CQ36699277-2AB17AE2-9F25-4BAC-A6BF-4A0300A68DF2Q37124646-D75EBD06-DA76-4772-80B9-9EB40FD28E95Q37629667-2FDA633C-079C-478D-9BA3-002241EBE9B9Q37693420-E731B984-3D53-4047-B647-AF0079793524Q41683132-08EB146A-AE6D-41D3-8575-9382C5938643Q41857666-5AE8F34A-7BF4-474A-A218-470C70122C48Q42117546-795108A8-5323-4F9F-B566-87AC01DD2C3CQ44873639-FA6F3166-1E2D-4B2D-8923-FE572BA73A39Q47731713-E3736EE9-68A7-473B-96B0-7269F69C521DQ49411135-BE7AA05A-0B43-432E-BB7D-E1BA4F69D55DQ50077577-CB1173AB-0329-441F-B972-60C4688DF094Q50351674-1606FAEF-9D93-4440-A0CB-3B2AB083A035Q53626387-0AB0C7B3-B597-429D-A1D3-346DA6ECADE2
P2860
Expression of corticotropin releasing factor receptor type 1 (CRF1) in the human gastrointestinal tract and upregulation in the colonic mucosa in patients with ulcerative colitis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Expression of corticotropin re ...... ients with ulcerative colitis.
@en
type
label
Expression of corticotropin re ...... ients with ulcerative colitis.
@en
prefLabel
Expression of corticotropin re ...... ients with ulcerative colitis.
@en
P2093
P2860
P1433
P1476
Expression of corticotropin re ...... ients with ulcerative colitis.
@en
P2093
Ekaterini Chatzaki
Julie Elliott
Peter A Anton
Pu-Qing Yuan
S Vincent Wu
P2860
P356
10.1016/J.PEPTIDES.2012.07.028
P577
2012-08-28T00:00:00Z